To include your compound in the COVID-19 Resource Center, submit it here.

Inhibiting ADAM10 could help treat brain cancer

In a paper published in Nature, researchers at Stanford University and colleagues showed that glioma growth is dependent on neuroligin 3 (NLGN3), and that inhibiting ADAM metallopeptidase domain

Read the full 285 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE